Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
A 40-year-old patient with severe haemophilia A and an inhibitor against factor VIII underwent a cataract extraction under local anaesthesia. Recombinant activated factor VII was use to achieve haemostasis. The procedure was successful. Neither bleeding complications nor side effects occurred.
Biron-Andréani
C
C
Laboratory of Haematology, University Hospital Montpellier-Nîmes, Montpellier, France.
Dupeyron
G
G
Mainemer
M
M
Schved
J F
JF
D000328:Adult; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D002386:Cataract / Q000150:complications; D002387:Cataract Extraction; D005169:Factor VIII / Q000276:immunology*; D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006488:Hemostasis, Surgical; D006801:Humans; D007518:Isoantibodies / Q000276:immunology*; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*
D007518:Isoantibodies; D011994:Recombinant Proteins; D005169:Factor VIII; D015942:Factor VIIa